Assignee
EPIMMUNE INC
US·13 granted patents·5 pending applications·1,007 citations·filing 1993–2015
Top patents by PatentIndex Score
18 records- 0197US6037135AMethods for making HLA binding peptides and their usesEPIMMUNE INC·Filed 1993·Granted Mar 14, 2000·308 cites·68 claims
- 0296US7026443B1Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2000·Granted Apr 11, 2006·92 cites·10 claims
- 0396US6602510B1HLA class I A2 tumor associated antigen peptides and vaccine compositionsEPIMMUNE INC·Filed 2000·Granted Aug 5, 2003·94 cites·11 claims
- 0494US6534482B1Expression vectors for stimulating an immune response and methods of using the sameEPIMMUNE INC·Filed 1999·Granted Mar 18, 2003·155 cites·4 claims
- 0592US7888472B2Optimized multi-epitope constructs and uses thereofEPIMMUNE INC·Filed 2009·Granted Feb 15, 2011·12 cites·6 claims
- 0690US6419931B1Compositions and methods for eliciting CTL immunityEPIMMUNE INC·Filed 1994·Granted Jul 16, 2002·94 cites·27 claims
- 0788US6413935B1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 1997·Granted Jul 2, 2002·73 cites·52 claims
- 0884US6689363B1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 1999·Granted Feb 10, 2004·69 cites·55 claims
- 0979US6413517B1Identification of broadly reactive DR restricted epitopesEPIMMUNE INC·Filed 1998·Granted Jul 2, 2002·40 cites·2 claims
- 1076US6464980B1MAGE-1 c-terminal immunogenic peptidesEPIMMUNE INC·Filed 1996·Granted Oct 15, 2002·23 cites·5 claims
- 1172US6322789B1HLA-restricted hepatitis B virus CTL epitopesEPIMMUNE INC·Filed 1995·Granted Nov 27, 2001·44 cites·22 claims
- 1271US8017745B2Plasmodium falciparum antigens and methods of useEPIMMUNE INC·Filed 2003·Granted Sep 13, 2011·3 cites·38 claims
- 1358US2006093617A1Peptides for inducing a CTL and/or HTL response to hepatitis C virusEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 1455US9789181B2PAN-DR binding polypeptides and uses thereofEPIMMUNE INC·Filed 2015·Granted Oct 17, 2017·0 cites·12 claims
- 1555US2004157780A1CTL inducing peptides from c-erb2 (HER-2/neu)EPIMMUNE INC·Filed 2004·Application pending·0 cites
- 1654US2005049197A1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 2004·Application pending·0 cites
- 1749US2005271676A1Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 1848US2016193316A1Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid CompositionsEPIMMUNE INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EPIMMUNE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →